Project Grant H8G48160

This federal Cooperative Agreement award, provided by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements (CFDA 93.268) program, supports the District of Columbia Department of Health in establishing and maintaining comprehensive vaccination initiatives targeting vaccine-preventable diseases. The $2,400,373.00 award, effective July 1, 2025 through June 30, 2030, aims to increase vaccine confidence, improve...

This Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) provides $335,963 to the Washington State Department of Health to strengthen vaccine-preventable disease prevention and response in Washington through immunization and the Vaccines for Children program. The award, effective July 1, 2025 through June 30, 2030, supports a range of public health initiatives focused on controlling...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the Immunization Cooperative Agreements program (CFDA 93.268), provides $552,237 to the State of Alaska Department of Health to strengthen vaccine-preventable disease prevention and response efforts in Alaska. The award will support activities to enhance vaccination infrastructure, improve vaccine access, and promote vaccine confidence over a 5-year period from July 1, 2025 to June 30, 2030. As...

This $199,295 National Science Foundation project grant funded the development of a comparative online simulation tool for COVID-19 vaccine allocation strategies. Funded under the Biological Sciences program (CFDA 47.074), the Fred Hutchinson Cancer Research Center will create a mathematical model of SARS-CoV-2 transmission incorporating multiple vaccines, viral variants, and demographic factors. This model will then be used to develop a free, open-source, online comparative tool allowing up...

This Cooperative Agreement award of $3,487,652.00 from the U.S. Centers for Disease Control and Prevention (CDC), under the Immunization Cooperative Agreements (CFDA 93.268) program, will support the Indiana Department of Health (IDOH) in strengthening vaccine-preventable disease prevention and response efforts over the five-year period from July 1, 2025 to June 30, 2030. The award will enable IDOH to establish and maintain comprehensive vaccination initiatives targeting diseases such as...

This Project Grant award from the National Institute on Minority Health and Health Disparities (NIMHD), under CFDA Program 93.307 Minority Health and Health Disparities Research, will fund a study to quantify COVID-19 vaccine coverage and general vaccine hesitancy among adolescents in rural areas of the United States. The total award amount is $393,750.00 with a project period from August 24, 2024 to April 1, 2025. The research will analyze existing data from the 2022-2023 National...

The National Science Foundation (NSF) awarded a $448,823 Project Grant under its Social, Behavioral, and Economic Sciences program (CFDA 47.075) to the Trustees of Boston University. This two-year grant, running from September 1, 2023 to August 31, 2025, aims to assess the effectiveness of various health communication tactics employed by federal, state, and local agencies to encourage vaccine uptake. The project will build a database of vaccine messaging from public health agencies, evaluate the...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) provides $420,998.00 to the State of North Carolina Department of Health & Human Services (NC DHHS) for the program entitled "NORTH CAROLINA'S IMMUNIZATION AND VACCINES FOR CHILDREN GRANT YEAR 1 STRENGTHENING VACCINE-PREVENTABLE DISEASE PREVENTION AND RESPONSE". The funding will support North Carolina's efforts to...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements program (CFDA 93.268) provides $2,875,590.00 to the Utah Department of Health and Human Services (UDHHS) to strengthen vaccine-preventable disease prevention and response efforts. The 5-year award, effective July 1, 2025 through June 30, 2030, supports UDHHS in establishing and maintaining comprehensive vaccination initiatives targeting diseases such as...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements program (CFDA 93.268) provides $4,738,790 to the Department of Public Health Connecticut to strengthen vaccine-preventable disease prevention and response efforts in the state. The five-year award, running from July 1, 2025 to June 30, 2030, will support activities to enhance vaccination infrastructure, improve vaccine access, and promote vaccine confidence. As...